Cargando…

Enhanced caveolin-1 expression increases migration, anchorage-independent growth and invasion of endometrial adenocarcinoma cells

BACKGROUND: Caveolin-1 (CAV1) has been implicated both in tumor suppression and progression, whereby the specific role appears to be context dependent. Endometrial cancer is one of the most common malignancies of the female genital tract; however, little is known about the role of CAV1 in this disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Diaz-Valdivia, Natalia, Bravo, Denisse, Huerta, Hernán, Henriquez, Soledad, Gabler, Fernando, Vega, Margarita, Romero, Carmen, Calderon, Claudia, Owen, Gareth I., Leyton, Lisette, Quest, Andrew F. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460862/
https://www.ncbi.nlm.nih.gov/pubmed/26054531
http://dx.doi.org/10.1186/s12885-015-1477-5
_version_ 1782375448648351744
author Diaz-Valdivia, Natalia
Bravo, Denisse
Huerta, Hernán
Henriquez, Soledad
Gabler, Fernando
Vega, Margarita
Romero, Carmen
Calderon, Claudia
Owen, Gareth I.
Leyton, Lisette
Quest, Andrew F. G.
author_facet Diaz-Valdivia, Natalia
Bravo, Denisse
Huerta, Hernán
Henriquez, Soledad
Gabler, Fernando
Vega, Margarita
Romero, Carmen
Calderon, Claudia
Owen, Gareth I.
Leyton, Lisette
Quest, Andrew F. G.
author_sort Diaz-Valdivia, Natalia
collection PubMed
description BACKGROUND: Caveolin-1 (CAV1) has been implicated both in tumor suppression and progression, whereby the specific role appears to be context dependent. Endometrial cancer is one of the most common malignancies of the female genital tract; however, little is known about the role of CAV1 in this disease. METHODS: Here, we first determined by immunohistochemistry CAV1 protein levels in normal proliferative human endometrium and endometrial tumor samples. Then using two endometrial cancer cell lines (ECC: Ishikawa and Hec-1A) we evaluated mRNA and protein levels of CAV1 by real time qPCR and Western blot analysis, respectively. The role of CAV1 expression in ECC malignancy was further studied by either inducing its expression in endometrial cancer cells with the tumor promotor 12-O-tetradecanoyl-phorbol-13-acetate (4β-TPA) or decreasing expression using short-hairpin RNA constructs, and then evaluating the effects of these changes on ECC proliferation, transmigration, matrigel invasion, and colony formation in soft agar. RESULTS: Immunohistochemical analysis of endometrial epithelia revealed that substantially higher levels of CAV1 were present in endometrial tumors than the normal proliferative epithelium. Also, in Ishikawa and Hec-1A endometrial cancer cells CAV1 expression was readily detectable. Upon treatment with 4β-TPA CAV1 levels increased and coincided with augmented cell transmigration, matrigel invasion, as well as colony formation in soft agar. Reduction of CAV1 expression using short-hairpin RNA constructs ablated these effects in both cell types whether treated or not with 4β-TPA. Alternatively, CAV1 expression appeared not to modulate significantly proliferation of these cells. CONCLUSION: Our study shows that elevated CAV1, observed in patients with endometrial cancer, is linked to enhanced malignancy of endometrial cancer cells, as evidenced by increased migration, invasion and anchorage-independent growth. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1477-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4460862
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44608622015-06-10 Enhanced caveolin-1 expression increases migration, anchorage-independent growth and invasion of endometrial adenocarcinoma cells Diaz-Valdivia, Natalia Bravo, Denisse Huerta, Hernán Henriquez, Soledad Gabler, Fernando Vega, Margarita Romero, Carmen Calderon, Claudia Owen, Gareth I. Leyton, Lisette Quest, Andrew F. G. BMC Cancer Research Article BACKGROUND: Caveolin-1 (CAV1) has been implicated both in tumor suppression and progression, whereby the specific role appears to be context dependent. Endometrial cancer is one of the most common malignancies of the female genital tract; however, little is known about the role of CAV1 in this disease. METHODS: Here, we first determined by immunohistochemistry CAV1 protein levels in normal proliferative human endometrium and endometrial tumor samples. Then using two endometrial cancer cell lines (ECC: Ishikawa and Hec-1A) we evaluated mRNA and protein levels of CAV1 by real time qPCR and Western blot analysis, respectively. The role of CAV1 expression in ECC malignancy was further studied by either inducing its expression in endometrial cancer cells with the tumor promotor 12-O-tetradecanoyl-phorbol-13-acetate (4β-TPA) or decreasing expression using short-hairpin RNA constructs, and then evaluating the effects of these changes on ECC proliferation, transmigration, matrigel invasion, and colony formation in soft agar. RESULTS: Immunohistochemical analysis of endometrial epithelia revealed that substantially higher levels of CAV1 were present in endometrial tumors than the normal proliferative epithelium. Also, in Ishikawa and Hec-1A endometrial cancer cells CAV1 expression was readily detectable. Upon treatment with 4β-TPA CAV1 levels increased and coincided with augmented cell transmigration, matrigel invasion, as well as colony formation in soft agar. Reduction of CAV1 expression using short-hairpin RNA constructs ablated these effects in both cell types whether treated or not with 4β-TPA. Alternatively, CAV1 expression appeared not to modulate significantly proliferation of these cells. CONCLUSION: Our study shows that elevated CAV1, observed in patients with endometrial cancer, is linked to enhanced malignancy of endometrial cancer cells, as evidenced by increased migration, invasion and anchorage-independent growth. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1477-5) contains supplementary material, which is available to authorized users. BioMed Central 2015-06-10 /pmc/articles/PMC4460862/ /pubmed/26054531 http://dx.doi.org/10.1186/s12885-015-1477-5 Text en © Diaz et al. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Diaz-Valdivia, Natalia
Bravo, Denisse
Huerta, Hernán
Henriquez, Soledad
Gabler, Fernando
Vega, Margarita
Romero, Carmen
Calderon, Claudia
Owen, Gareth I.
Leyton, Lisette
Quest, Andrew F. G.
Enhanced caveolin-1 expression increases migration, anchorage-independent growth and invasion of endometrial adenocarcinoma cells
title Enhanced caveolin-1 expression increases migration, anchorage-independent growth and invasion of endometrial adenocarcinoma cells
title_full Enhanced caveolin-1 expression increases migration, anchorage-independent growth and invasion of endometrial adenocarcinoma cells
title_fullStr Enhanced caveolin-1 expression increases migration, anchorage-independent growth and invasion of endometrial adenocarcinoma cells
title_full_unstemmed Enhanced caveolin-1 expression increases migration, anchorage-independent growth and invasion of endometrial adenocarcinoma cells
title_short Enhanced caveolin-1 expression increases migration, anchorage-independent growth and invasion of endometrial adenocarcinoma cells
title_sort enhanced caveolin-1 expression increases migration, anchorage-independent growth and invasion of endometrial adenocarcinoma cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460862/
https://www.ncbi.nlm.nih.gov/pubmed/26054531
http://dx.doi.org/10.1186/s12885-015-1477-5
work_keys_str_mv AT diazvaldivianatalia enhancedcaveolin1expressionincreasesmigrationanchorageindependentgrowthandinvasionofendometrialadenocarcinomacells
AT bravodenisse enhancedcaveolin1expressionincreasesmigrationanchorageindependentgrowthandinvasionofendometrialadenocarcinomacells
AT huertahernan enhancedcaveolin1expressionincreasesmigrationanchorageindependentgrowthandinvasionofendometrialadenocarcinomacells
AT henriquezsoledad enhancedcaveolin1expressionincreasesmigrationanchorageindependentgrowthandinvasionofendometrialadenocarcinomacells
AT gablerfernando enhancedcaveolin1expressionincreasesmigrationanchorageindependentgrowthandinvasionofendometrialadenocarcinomacells
AT vegamargarita enhancedcaveolin1expressionincreasesmigrationanchorageindependentgrowthandinvasionofendometrialadenocarcinomacells
AT romerocarmen enhancedcaveolin1expressionincreasesmigrationanchorageindependentgrowthandinvasionofendometrialadenocarcinomacells
AT calderonclaudia enhancedcaveolin1expressionincreasesmigrationanchorageindependentgrowthandinvasionofendometrialadenocarcinomacells
AT owengarethi enhancedcaveolin1expressionincreasesmigrationanchorageindependentgrowthandinvasionofendometrialadenocarcinomacells
AT leytonlisette enhancedcaveolin1expressionincreasesmigrationanchorageindependentgrowthandinvasionofendometrialadenocarcinomacells
AT questandrewfg enhancedcaveolin1expressionincreasesmigrationanchorageindependentgrowthandinvasionofendometrialadenocarcinomacells